INCY - Incyte Q1 2024 Earnings Preview
2024-04-29 11:44:31 ET
More on Incyte
- Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade)
- Incyte: A Potential GARP Superstar
- Incyte Corporation (INCY) Q4 2023 Earnings Call Transcript
- Incyte to acquire immune-focused drug developer Escient
- Incyte and CMS collaborate for povorcitinib in Mainland China, Hong Kong, Macau, Taiwan and SEA